Skip to content

Jeff Sutherland

Twice the Energy with Half the Stress

Combating COVID Flu and ACIRD in Humans and Pets: Frequency Research Foundation’s Approach

At the Frequency Research Foundation, our commitment to addressing global health crises has led us to a significant discovery in the fight against COVID flu. Not only have we identified the complex nature of multiple COVID flu strains circulating globally, but we have also recognized their impact across species, including a notable strain known as ACIRD in dogs. This understanding has propelled our efforts to develop remote, non-invasive technologies aimed at combating these infections in humans, animals, and even the spaces we inhabit.

Understanding the Multi-Faceted Nature of COVID Flu

COVID flu complexes identified by Frequency Research Foundation exhibit intricate and varied pathogenic profiles, spread through airborne parasites. Unlike traditional flu strains that target individuals, the February 2023 COVID flu can infiltrate entire ecosystems, infecting canines with ACIRD and posing risks to human family members and their surroundings. This flu spreads through multiple strains of the ancylostoma parasite in aerosol form, persisting not only within lung tissues but also on surfaces and within building ventilation systems.

Our Comprehensive Treatment Approach

Given the extensive nature of these infections, a comprehensive treatment approach is essential. Frequency Research Foundation has taken a significant step by offering a set of frequencies designed to combat the February 2023 COVID flu, now available for free to the public. These frequencies are intended for use in treating individuals, animals afflicted with ACIRD, and sanitizing the spaces they occupy. This holistic approach recognizes the interconnectedness of human and animal health with their living environments.

The Urgency of Environmental Decontamination

The revelation that the February 2023 COVID flu can infiltrate buildings underscores the critical need for environmental decontamination. The Foundation’s initiative to provide frequencies for building treatment is crucial in curbing the disease’s spread. By addressing the infectious threat at all levels – personal, animal, and environmental – we can hope to mitigate the impact of the COVID flu and protect entire communities.

Moving Forward with Frequency-Based Health Innovations

The discovery of multiple circulating COVID flu strains emphasizes the need for ongoing vigilance and innovation in health sciences. Frequency Research Foundation’s efforts represent a vital resource in addressing this global health challenge. As we confront the realities of the COVID flu, the Foundation’s work becomes increasingly crucial. By leveraging frequencies to treat the complex web of pathogens associated with the COVID flu, we open the door to more effective health solutions for our interconnected world.

Navigating the Persistent Waves of COVID Flu: Insights from Frequency Research Foundation

Upadate: The COVID Flu from Feb 2023 has evolved into a full blown syndrome affecting dogs (ACRID) as well as people and buildings. Circulating for more than a year now it is very infectious and persistent. Multiple researches have helped to expand its already large frequency set by identifying new organisms DNA sequenced in government databases.

As 2023 unfolded, we at the Frequency Research Foundation witnessed a recurring global health challenge – the COVID flu. Our extensive client base, spread across the globe, becomes a real-time map tracing the rapid spread of flu viruses. Unlike seasonal flus, the COVID flus of 2023, robust and persistent, are not bound by weather or season. They bring with them a cocktail of pathogens – flu viruses, multiple strains of COVID, and a variety of parasites, bacteria, fungi, and even mycoplasma.

A Year-Long Battle Against a Formidable Foe

Our encounters with these flus have shown that they are not fleeting; they linger for weeks, sometimes months. In one extraordinary case, we observed flu symptoms persisting for a full year until frequencies successfully eliminated them. This enduring presence challenges the conventional understanding of flu and its treatment.

Unlocking the Secret of Stubborn Flus

Twenty years of research have shed light on the tenacious nature of flu. Frequencies, with their inherent precision and reliability, have revealed that it’s not just a single virus at play. We’ve discovered that an airborne parasite, alarmingly infectious, is the vector transporting these pathogens. This large parasite has the unique ability to infect people, animals, and even buildings.

The Swine Flu epidemic was a stark manifestation of this phenomenon, with airports becoming super-spreaders. Since standard flu treatments target only the virus, the actual flu persists until the parasitic vectors die naturally – which takes much longer than anticipated.

A Proactive Approach to a Global Health Menace

When someone approaches us with flu symptoms, our priority is to identify all associated organisms. As we treat more cases, our database grows, leading to a more comprehensive set of frequencies that can potentially conquer the flu in mere days.

Boiron’s Oscillicoccinum 200, a homeopathic remedy, has proven to be an effective adjunct, facilitating the rapid elimination of flu organisms when combined with our frequency treatments at the onset of symptoms.

The Pervasive Threat of COVID Flus

The COVID flus stand out in their infectiousness. Simple activities, like a visit to Starbucks or a routine medical checkup, can result in multiple reinfections. Recognizing the public health crisis at hand, we’ve decided to release these frequencies free of charge to support experienced Rife practitioners. For those who are new to this, our Photoanalysis Remote Rife Clinic stands ready to assist you, your animals, and even sanitize your living spaces from the COVID flu, with the goal of achieving this ideally within a day, barring complications from co-infections.

Masking Up: A Double-Edged Sword

Our research indicates that while masks might not be the ultimate barrier against viruses due to their minuscule size, they do offer protection against the larger organisms responsible for spreading the flu. Data from the period of 2020-2022 align with our findings, as mask-wearing did not significantly impact the spread of COVID but did contribute to a substantial decline in traditional flu cases.


As we continue to navigate the waves of the COVID flu, the Frequency Research Foundation remains dedicated to providing innovative solutions that are validated by two decades of unwavering research. We urge the scientific community to examine our work with an open mind and welcome the opportunity to collaborate in advancing the understanding of frequency-based therapies.

Long COVID – at least 65M people worldwide

Long COVID: major findings, mechanisms and recommendations
Hannah E. Davis, Lisa McCorkell, Julia Moore Vogel & Eric J. Topol 

nature reviews microbiology

Long COVID is an often debilitating illness that occurs in at least 10%
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infections. More than 200 symptoms have been identifed with impacts
on multiple organ systems. At least 65 million individuals worldwide are
estimated to have long COVID, with cases increasing daily. Biomedical
research has made substantial progress in identifying various
pathophysiological changes and risk factors and in characterizing
the illness; further, similarities with other viral-onset illnesses such as
myalgic encephalomyelitis/chronic fatigue syndrome and postural
orthostatic tachycardia syndrome have laid the groundwork for
research in the feld. In this Review, we explore the current literature
and highlight key fndings, the overlap with other conditions, the
variable onset of symptoms, long COVID in children and the impact of
vaccinations. Although these key fndings are critical to understanding
long COVID, current diagnostic and treatment options are insufcient,
and clinical trials must be prioritized that address leading hypotheses.
Additionally, to strengthen long COVID research, future studies must
account for biases and SARS-CoV-2 testing issues, build on viral-onset
research, be inclusive of marginalized populations and meaningfully
engage patients throughout the research process.

Many of the clients we work with in our Photoanalysis Remote Rife Frequency Clinic have long COVID.

COVID-19 Vaccine Injury, Syndrome Not a Disease: FLCCC Conference Shares How to Treat It

The complex myriad of symptoms in people suspecting of COVID-19 vaccine injury has been given a new name and an extensive treatment protocol:

“Post-COVID-19 vaccines syndrome,” said Dr. Paul Marik, co-founder and Chief Science Officer of the Frontline COVID-19 Critical Care Alliance (FLCCC), on Oct. 15 at a conference in Orlando, Florida, aimed at education and sharing information on treating spike protein-induced health issues.

The Photoanalysis Remote Rife Clinic is specifically designed to help people with the multiple syndromes associated with COVID-19 and long COVID aftereffects. We were recently asked to work with an 86 year old women who went to emergency care and was told she could not come into the building and needed to wait outside on a park bench in sub-freezing weather. After an extended period of waiting with no-one showing up to help her she left. It is not a good idea to depend on a system that is crumbling and failing to help patients.

The SARS-CoV-2 Spike Protein is vulnerable to moderate electric fields

March 2021
License CC BY 4.0 - download PDF
Claudia ArbeitmanClaudia ArbeitmanPablo RojasPedro A Ojeda-MayPedro A Ojeda-May Martin Garcia

ABSTRACT: Most of the ongoing projects aimed at the development of specific therapies and vaccines against COVID-19 use the SARS-CoV-2 spike (S) protein as the main target [1-3]. The binding of the spike protein with the ACE2 receptor (ACE2) of the host cell constitutes the first and key step for virus entry. During this process, the receptor binding domain (RBD) of the S protein plays an essential role, since it contains the receptor binding motif (RBM), responsible for the docking to the receptor. So far, mostly biochemical methods are being tested in order to prevent binding of the virus to ACE2 [4]. Here we show, with the help of atomistic simulations, that external electric fields of easily achievable and moderate strengths can dramatically destabilise the S protein, inducing long-lasting structural damage. One striking field-induced conformational change occurs at the level of the recognition loop L3 of the RBD where two parallel beta sheets, believed to be responsible for a high affinity to ACE2 [5], undergo a change into an unstructured coil, which exhibits almost no binding possibilities to the ACE2 receptor (Figure 1a). Remarkably, while the structural flexibility of S allows the virus to improve its probability of entering the cell, it is also the origin of the surprising vulnerability of S upon application of electric fields of strengths at least two orders of magnitude smaller than those required for damaging most proteins. Our findings suggest the existence of a clean physical method to weaken the SARS-CoV-2 virus without further biochemical processing. Moreover, the effect could be used for infection prevention purposes and also to develop technologies for in-vitro structural manipulation of S. Since the method is largely unspecific, it can be suitable for application to mutations in S, to other proteins of SARS-CoV-2 and in general to membrane proteins of other virus types.

Magnetex – Adjuvant Therapy for COVID Damage

Application of Rotating Magnetic Fields Increase the Activity of Antimicrobials Against Wound Biofilm Pathogens

Scientific Reports volume 8, Article number: 167 (2018) Cite this article


Infective complications are a major factor contributing to wound chronicity and can be associated with significant morbidity or mortality. Wound bacteria are protected in biofilm communities and are highly resistant to immune system components and to antimicrobials used in wound therapy.


COVID spikes have been developed in bioweapons labs and research centers in many parts of the world. Forensic analysis shows hundreds of patents over the last several decades along with many hundreds of research papers. For example, Nature Biotechnology maps the network of patents directly related to COVID vaccines.

The coronavirus spike causes significant damage to arteries along with opportunistic infections that cause immediate and long term COVID effects. With the addition of the vaccine there are even more spikes along with coagulation of the blood with can cause blood clots.

Black veins in legs that can be cleared up with Magnetex.

Frequencies can disrupt the spike proteins and associated pathogens. However, many infected individuals present with aches and pain all over the body, COVID rashes, inflamed varicose veins, COVID toes, heart disease, brain aneurisms, and so forth. Rotating magnetic fields along with vibration applied to infected areas can accelerate the destruction of spike proteins, flush out associated pathogens and biofilms and loosen up coagulated blood.

The Magnetex,org product has been useful in conjuction with frequencies assisting in long term COVID problems, particular for paint in joints and in the back, COVID rashes, and inflamed varicose veins. It is a research device so it must be used as instructed by the vendor and use is at your own risk.

COVID-19 Vaccine Boosters for Young Adults: A Risk-Benefit Assessment and Five Ethical Arguments against Mandates at Universities

50 Pages Posted: 12 Sep 2022

Kevin Bardosh

University of Washington; University of Edinburgh – Edinburgh Medical School

Allison Krug

Artemis Biomedical Communications LLC

Euzebiusz Jamrozik

University of Oxford

Trudo Lemmens

University of Toronto – Faculty of Law

Salmaan Keshavjee

Harvard University – Harvard Medical School

Vinay Prasad

University of California, San Francisco (UCSF)

Martin A. Makary

Johns Hopkins University – Department of Surgery

Stefan Baral

John Hopkins University

Tracy Beth Høeg

Florida Department of Health; Sierra Nevada Memorial Hospital

Date Written: August 31, 2022


Students at North American universities risk disenrollment due to third dose COVID-19 vaccine mandates. We present a risk-benefit assessment of boosters in this age group and provide five ethical arguments against mandates. We estimate that 22,000 – 30,000 previously uninfected adults aged 18-29 must be boosted with an mRNA vaccine to prevent one COVID-19 hospitalisation. Using CDC and sponsor-reported adverse event data, we find that booster mandates may cause a net expected harm: per COVID-19 hospitalisation prevented in previously uninfected young adults, we anticipate 18 to 98 serious adverse events, including 1.7 to 3.0 booster-associated myocarditis cases in males, and 1,373 to 3,234 cases of grade ≥3 reactogenicity which interferes with daily activities. Given the high prevalence of post-infection immunity, this risk-benefit profile is even less favourable. University booster mandates are unethical because: 1) no formal risk-benefit assessment exists for this age group; 2) vaccine mandates may result in a net expected harm to individual young people; 3) mandates are not proportionate: expected harms are not outweighed by public health benefits given the modest and transient effectiveness of vaccines against transmission; 4) US mandates violate the reciprocity principle because rare serious vaccine-related harms will not be reliably compensated due to gaps in current vaccine injury schemes; and 5) mandates create wider social harms. We consider counter-arguments such as a desire for socialisation and safety and show that such arguments lack scientific and/or ethical support. Finally, we discuss the relevance of our analysis for current 2-dose CCOVIDovid-19 vaccine mandates in North America.

Note: Funding: This paper was partially supported by a Wellcome Trust Society and Ethics fellowship awarded to KB (10892/B/15/ZE) and Wellcome Trust grants to EJ (216355, 221719, 203132).
Competing Interest Statement: We do not have any competing interests to declare.

Keywords: COVID-19 vaccines, mandates, ethics, young adults, risk-benefit analysis

Suggested Citation:

Bardosh, Kevin and Krug, Allison and Jamrozik, Euzebiusz and Lemmens, Trudo and Keshavjee, Salmaan and Prasad, Vinay and Makary, Martin A. and Baral, Stefan and Høeg, Tracy Beth, COVID-19 Vaccine Boosters for Young Adults: A Risk-Benefit Assessment and Five Ethical Arguments against Mandates at Universities (August 31, 2022). Available at SSRN: or

Blood abnormalities found in people with Long Covid

As mentioned previous 30-70% of people have Long Covid symptoms. Science has just published a study on blood abnormalities that cause heart problems and abnormal large blood clots that are being reported by undertakers.

An ambitious study of people with Long Covid, the mysterious, disabling symptoms that can trail a SARS-CoV-2 infection, has turned up a host of abnormalities in their blood. The clues add to a body of evidence hinting at drivers of the condition and potential treatments worth testing. They also suggest that, as many scientists and patients have suspected, Long Covid shares certain features with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), another condition thought to follow an infection.

The new Long Covid project began in late 2020, when Yale University immunologist Akiko Iwasaki teamed up with David Putrino, a neurophysiologist at the Icahn School of Medicine at Mount Sinai who was caring for affected patients. The pair wanted to compare those patients with people who had never been infected—and those who had recovered. To Putrino’s surprise, “It was quite challenging to find people who were fully recovered from COVID.” Many post–COVID-19 volunteers described themselves as healthy but then admitted, for example, that their once-normal gym workouts were too exhausting to resume.”

Contaminants in the vaccine not only cause these problems, they reduce immune function to 60% of normal in every vaccinated person that we test at Frequency Research Foundation. Through shedding the non-vaccinated can have the same disfunctional immune system.

This is serious as it can even cause professional sports players in prime physical condition to drop dead on the field from heart failure. We have spent years identifying every toxin component in the blood of those with Long Covid symptoms and they can be removed in a few hours by running a FREE frequency program.

You might try it as your well being depends on it.

Residual COVID – Everyone Has It

All types of disease catogories are appearing anonymously in individuals with a negative COVID test. Sudden Adult Death Syndrome is just the latest label given to patients who physicians don’t understand. Recently Frequency Research Foundation has worked with people who have lost sensation in the right leg and gone to the emergency room in the middle of the night. Scanning reveals residual COVID strains in right leg. Similarly for a marathon runner who had trouble walking up the stairs because he had problems lifting his right foot. Or a current client with kidney pain. Or a martial artist with throat problems that are mysterious to physicians and might be cancer. Or a sister of one of our staff who passed away mysteriously one night because her heart simply stopped beating.

All of these problems are potentially avoidable by deep scanning of organ systems for residual strains of COVID and elimination of these strains through remote frequency work. If clients have their own frequency hardware frequencies can be applied locally as well.

The basic frequencies for this work are free globally under a Creative Commons Share and Share Alike license. Detailed COVID strain frequencies are available free to subscribers or for a small charge to non-subcribers.

Those familiar with frequency work often chose to be part of our clinic program to get scanned every week with remote frequencies run to clear out their system. The price of this program has been reduced to the price of a monthly supplement so that some clients choose to stay on it indefinitely.

Autopsies of COVID-19 patients reveal clotting concerns

Filed Under: COVID-19Mary Van Beusekom | News Writer | CIDRAP News  | May 07, 2020

study of autopsy findings of the first 12 patients who died of COVID-19 in a hospital in Hamburg, Germany, has found that 7 (58%) of them had undiagnosed deep vein thrombosis, suggesting that the virus may cause abnormal blood clotting.

In the prospective cohort study, published yesterday in the Annals of Internal Medicine, researchers discovered that the direct cause of death in four patients was massive pulmonary embolism from deep vein blood clots in the legs that lodged in a lung artery, causing a blockage. Read more.

A pathogen doing his own research on autopsy tissue sees the spikes as the toxin part of COVID-19. They attach to the lining of the arteries and cause microclots that are not visible on radiology scans. He describes specifically how the immune system is disrupted by this process which causes increased susceptibility to viruses and 10-20 times higher incidence of certain cancers.

Frequency Research Foundation has identified micro blood clots consistently in scans of those infected with COVID. Vaccination may accelerate this clotting and appears to be the major cause of the deaths of the over 12000 registered deaths in the VAERS government database. This phenomenon in the brain, heart, lungs, or reproductive organs can cause long term disability in survivors.

New Cause of COVID-19 Blood Clots Identified

A new study reveals the virus triggers production of antibodies circulating through the blood, causing clots in people hospitalized with the disease.

red blood vessel with purple clot and antivodies floating inside

Stephanie King

Blood clots continue to wreak havoc for patients with severe COVID-19 infection, and a new study explains what may spark them in up to half of patients.

The culprit: an autoimmune antibody that’s circulating in the blood, attacking the cells and triggering clots in arteries, veins, and microscopic vessels. Blood clots can cause life-threatening events like strokes. And, in COVID-19, microscopic clots may restrict blood flow in the lungs, impairing oxygen exchange.

Outside of novel coronavirus infection, these clot-causing antibodies are typically seen in patients who have the autoimmune disease antiphospholipid syndrome. The connection between autoantibodies and COVID-19 was unexpected, says co-corresponding author Yogen Kanthi, M.D., an assistant professor at the Michigan Medicine Frankel Cardiovascular Center and a Lasker Investigator at the National Institutes of Health’s National Heart, Lung, and Blood Institute.

“In patients with COVID-19, we continue to see a relentless, self-amplifying cycle of inflammation and clotting in the body,” Kanthi says. “Now we’re learning that autoantibodies could be a culprit in this loop of clotting and inflammation that makes people who were already struggling even sicker.”

‘Some of the worst clotting we’ve ever seen’

Co-corresponding author Jason Knight, M.D., Ph.D., a rheumatologist at Michigan Medicine, has been studying antiphospholipid syndrome antibodies in the general population for years.

“Half of the patients hospitalized with COVID-19 were positive for at least one of the autoantibodies, which was quite a surprise,” says Knight, also an associate professor of internal medicine and a leading expert on diseases caused by autoantibodies.

In the new Science Translational Medicine publication, they found about half of the patients who were very sick with COVID-19 were exhibiting a combination of high levels of both the dangerous antibodies and super-activated neutrophils, which are destructive, exploding white blood cells. In April, the team was the first to report that patients hospitalized for severe COVID-19 had higher levels of neutrophil extracellular traps in their blood.

To learn more, they studied the explosive neutrophils and the COVID-19 antibodies together in mouse models to see if this could be the dangerous combination behind the clots.

“Antibodies from patients with active COVID-19 infection created a striking amount of clotting in animals – some of the worst clotting we’ve ever seen,” Kanthi says. “We’ve discovered a new mechanism by which patients with COVID-19 may develop blood clots.”

desi mm story kyra dutt hot رسومات سكس نيك مرات العم khasi sex video find your milf قصص سكس مثيرة جدا السكس بكس jennifer kotwal riding porn
نيك الخدامه مقاطع سكس مترجم punjabi sexy blue video x vodeos sexy video open sex xvideos2 india جنس فلاحى نسوان ملط sunny leone 4x indian teen nude
desi videos xnxx www desibest indian xnxx latest blue film mp3 youtube sunita baby kamalika chanda instagram jones cup live kmjs latest episode xxxbunkers spark porn